[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025",
    "summary": "PRINCETON, N.J., October 25, 2025--BMS Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR.",
    "url": "https://finnhub.io/api/news?id=a45f48dfdeb9e642cd1bd204db64188166bd93c271ceb35d2658138dbf365238",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761404400,
      "headline": "Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025",
      "id": 137216790,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., October 25, 2025--BMS Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR.",
      "url": "https://finnhub.io/api/news?id=a45f48dfdeb9e642cd1bd204db64188166bd93c271ceb35d2658138dbf365238"
    }
  }
]